452 related articles for article (PubMed ID: 16246436)
1. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
[TBL] [Abstract][Full Text] [Related]
2. Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens.
Jezierski G; Zehle S; Bock J; Braun K; Gruss M
J Neurochem; 2007 Dec; 103(6):2234-44. PubMed ID: 17924950
[TBL] [Abstract][Full Text] [Related]
3. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
Kankaanpää A; Meririnne E; Seppälä T
Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
[TBL] [Abstract][Full Text] [Related]
6. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment.
Shen RY; Choong KC
Biol Psychiatry; 2006 Apr; 59(7):635-42. PubMed ID: 16199009
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats.
Izawa J; Yamanashi K; Asakura T; Misu Y; Goshima Y
Eur J Pharmacol; 2006 Nov; 549(1-3):84-90. PubMed ID: 16979160
[TBL] [Abstract][Full Text] [Related]
8. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
9. Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.
dos Santos Pereira M; Sathler MF; Valli Tda R; Marques RS; Ventura AL; Peccinalli NR; Fraga MC; Manhães AC; Kubrusly R
PLoS One; 2015; 10(10):e0141249. PubMed ID: 26509840
[TBL] [Abstract][Full Text] [Related]
10. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats.
Mague SD; Andersen SL; Carlezon WA
Biol Psychiatry; 2005 Jan; 57(2):120-5. PubMed ID: 15652869
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
dela Peńa IC; Ahn HS; Choi JY; Shin CY; Ryu JH; Cheong JH
Behav Pharmacol; 2011 Feb; 22(1):31-9. PubMed ID: 21160423
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate (Ritalin): behavioral studies in the rat.
Askenasy EP; Taber KH; Yang PB; Dafny N
Int J Neurosci; 2007 Jun; 117(6):757-94. PubMed ID: 17454243
[TBL] [Abstract][Full Text] [Related]
13. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA
Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
16. Adolescent and adult male spontaneous hyperactive rats (SHR) respond differently to acute and chronic methylphenidate (Ritalin).
Barron E; Yang PB; Swann AC; Dafny N
Int J Neurosci; 2009; 119(1):40-58. PubMed ID: 19116830
[TBL] [Abstract][Full Text] [Related]
17. Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
Reichel CM; Linkugel JD; Bevins RA
Exp Clin Psychopharmacol; 2007 Oct; 15(5):501-9. PubMed ID: 17924784
[TBL] [Abstract][Full Text] [Related]
18. Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment.
dela Peña I; Lee JC; Lee HL; Woo TS; Lee HC; Sohn AR; Cheong JH
Neurosci Lett; 2012 Apr; 514(2):189-93. PubMed ID: 22414863
[TBL] [Abstract][Full Text] [Related]
19. Altered responsiveness to cocaine in rats exposed to methylphenidate during development.
Andersen SL; Arvanitogiannis A; Pliakas AM; LeBlanc C; Carlezon WA
Nat Neurosci; 2002 Jan; 5(1):13-4. PubMed ID: 11731802
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.
Gerasimov MR; Franceschi M; Volkow ND; Rice O; Schiffer WK; Dewey SL
Synapse; 2000 Dec; 38(4):432-7. PubMed ID: 11044890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
